SVS Guidelines Bundle

Management of Diabetic Foot

SVS GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, Enjoy!

Issue link:

Contents of this Issue


Page 11 of 11

Disclaimer is Guideline attempts to define principles of practice that should produce high-quality patient care. It is applicable to specialists, primary care, and providers at all levels. is Guideline should not be considered exclusive of other methods of care reasonably directed at obtaining the same results. e ultimate judgment concerning the propriety of any course of conduct must be made by the clinician aer consideration of each individual patient situation. Neither IGC, the medical associations, nor the authors endorse any product or service associated with the distributor of this clinical reference tool. Abbreviations A1c, glycohemoglobin; ABI, ankle-brachial index; DFO, diabetic foot osteomyelitis; DFU, diabetic foot ulcer; HBO, hyperbaric oxygen; MRI, magnetic resonance imaging ; NPWT, negative pressure wound therapy; PAD, peripheral arterial disease; PDGF; platelet-derived growth factor; PTB, probe to bone; PVR, pulse volume recording ; SIRS, systemic inflammatory response syndrome; SPP, skin perfusion pressure; SVS, Society for Vascular Surgery; TCC, total contact cast; TcPO 2 , transcutaneous oxygen pressure; TMA, transmetatarsal amputation; TP, toe pressure; XR, radiography Source Hingorani A, LaMuraglia GM, Henke P, Meissner MH, Loretz L, Zinszer KM, Driver VR, Frykberg R, Carman TL, Marston W, Mills JL Sr, Murad MH. e management of diabetic foot: A clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine. J Vasc Surg 2016;63:3S-21S. 106 Commerce Street, Suite 105 Lake Mary, FL 32746 TEL: 407.878.7606 • FAX: 407.878.7611 Order additional copies at Copyright © 2016 All rights reserved Strength of Recommendation and Quality of Evidence Strength of Recommendation Quality of Evidence 1 – Strong Benefit clearly outweighs risk A High 2 – Weak Benefits and risks are more closely matched and are more dependent on specific clinical scenarios B Moderate C Low U Ungraded SVSDFI16051b

Articles in this issue

Links on this page

Archives of this issue

view archives of SVS Guidelines Bundle - Management of Diabetic Foot